Radiodermatitis
Conditions
Interventions
This is a randomized, carried out by a table of random numbers, double-blind clinical trial. Sample: patients diagnosed with cancer and indicated for radiotherapy treatment. Volunteers will be divided
E02.594.540
Sponsors
Universidade Federal de Santa Maria
Universidade Federal de Santa Maria
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Men and women; older than 18 years; diagnosed with cancer referred to the Santa Maria University Hospital physiotherapy outpatient clinic for physiotherapeutic treatment; with indication of radiotherapy
Exclusion criteria
Exclusion criteria: Unable to understand guidelines, such as those regarding the effects, protocol and care; volunteers who miss three more sessions; patients who have already received radiotherapy sessions; with skin cancer; pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that patients will not develop skin problems caused by radiotherapy evaluated by scale Radiation Therapy Oncology Group (RTOG) | — |
Secondary
| Measure | Time frame |
|---|---|
| It is hoped that radiodermatitis will not progress to more serious degrees evaluated by scale Radiation Therapy Oncology Group (RTOG) | — |
Countries
Brazil
Contacts
Public ContactHedioneia Pivetta
Universidade Federal de Santa Maria
Outcome results
None listed